Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0400 per EA under NDC 62756013902. Its NADAC has been published 393 times since Nov 28, 2013.
FDA first approved this application on Aug 24, 2006.
Strength
400 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756013902
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA077242FDA Approved
8/24/2006
On Market Since
2/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 393 times since Nov 28, 2013, and over the history we have for it it has declined 53.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0400 per EA |
|---|---|
| All-time high | $0.1011 (Feb 12, 2014) |
| All-time low | $0.0396 (Apr 22, 2026) |
| 52-week high | $0.0445 |
| 52-week low | $0.0396 |
| Median price | $0.0604 |
| Average price | $0.0628 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 393 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.0400 per EA (NDC 62756013902), effective Aug 19, 2026.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 53.6%. It has been tracked across 393 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Nov 28, 2013, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0396 (Apr 22, 2026) to a high of $0.1011 (Feb 12, 2014), with a median of $0.0604 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 400 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 62756013902) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.